Augmentation of endogenous cannabinoid tone modulates lipopolysaccharide‐induced alterations in circulating cytokine levels in rats
Open Access
- 5 September 2008
- journal article
- Published by Wiley in Immunology
- Vol. 125 (2) , 263-271
Abstract
Summary: The endogenous cannabinoid system plays an important role in regulating the immune system. Modulation of endogenous cannabinoids represents an attractive alternative for the treatment of inflammatory disorders. This study investigated the effects of URB597, a selective inhibitor of fatty acid amide hydrolase (FAAH), the enzyme catalysing degradation of the endogenous cannabinoid anandamide, and AM404, an inhibitor of anandamide transport, on lipopolysaccharide (LPS)‐induced increases in plasma cytokine levels in rats. Both URB597 and AM404 potentiated the LPS‐induced increase in plasma tumour necrosis factor‐α (TNF‐α) levels. The peroxisome proliferator‐activated receptor γ (PPARγ) antagonist, GW9662, attenuated the AM404‐induced augmentation of TNF‐α levels. Furthermore, the selective cannabinoid CB1and CB2receptor antagonists, AM251 and AM630 respectively, and the transient receptor potential vanilloid receptor‐1 (TRPV1) antagonist, SB366791, reduced LPS‐induced TNF‐α plasma levels both alone and in combination with AM404. In contrast, AM404 inhibited LPS‐induced increases in circulating interleukin‐1β (IL‐1β) and IL‐6. AM251 attenuated the immunosuppressive effect of AM404 on IL‐1β. None of the antagonists altered the effect of AM404 on LPS‐induced IL‐6. Moreover, AM251, AM630 and SB366791, administered alone, inhibited LPS‐induced increases in plasma IL‐1β and IL‐6 levels. In conclusion, inhibition of endocannabinoid degradation or transportin vivopotentiates LPS‐induced increases in circulating TNF‐α levels, an effect which may be mediated by PPARγ and is also reduced by pharmacological blockade of CB1, CB2and TRPV1. The immunosuppressive effect of AM404 on IL‐1β levels is mediated by the cannabinoid CB1receptor. Improved understanding of endocannabinoid‐mediated regulation of immune function has fundamental physiological and potential therapeutic significance.Keywords
This publication has 54 references indexed in Scilit:
- The orphan receptor GPR55 is a novel cannabinoid receptorBritish Journal of Pharmacology, 2007
- Cannabinoids go nuclear: evidence for activation of peroxisome proliferator‐activated receptorsBritish Journal of Pharmacology, 2007
- Inhibition of microglial fatty acid amide hydrolase modulates LPS stimulated release of inflammatory mediatorsFEBS Letters, 2007
- Antinociceptive effect of cannabinoid agonist WIN 55,212-2 in rats with a spinal cord injuryExperimental Neurology, 2007
- Anandamide mediates hyperdynamic circulation in cirrhotic rats via CB1 and VR1 receptorsBritish Journal of Pharmacology, 2006
- AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic painBritish Journal of Pharmacology, 2006
- A Role of PPAR-?? in Androstenediol-Mediated Salutary Effects on Cardiac Function Following Trauma-HemorrhageAnnals of Surgery, 2006
- PPAR-γ: A nuclear receptor with affinity for cannabinoidsLife Sciences, 2005
- Role of peroxisome proliferator-activated receptor-γ in the protection afforded by 15-deoxyΔ12,14 prostaglandin J2 against the multiple organ failure caused by endotoxinCritical Care Medicine, 2004
- Endocannabinoids, hormone-cytokine networks and human fertilityProstaglandins, Leukotrienes and Essential Fatty Acids, 2002